Wastewater data integration and modelling to accurately predict community and organizational outbreaks due to viral pathogens
废水数据集成和建模,以准确预测病毒病原体引起的社区和组织爆发
基本信息
- 批准号:10481536
- 负责人:
- 金额:$ 25.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-11 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressBiologicalCOVID-19COVID-19 diagnosisCOVID-19 monitoringCOVID-19 outbreakCOVID-19 pandemicCessation of lifeCommunitiesComplicationConsultContractsCost SavingsDataData AnalysesData ScienceDiagnosisDiseaseDisease OutbreaksEconomicsEffectivenessEpidemicFutureGrowthHIVHeadHealthHospitalizationHumanInfluenzaInternationalKnowledgeLeadLifeLocationMichiganModelingMunicipalitiesNorovirusPathway interactionsPersonsPhasePopulationPrevalencePublic HealthRecording of previous eventsReportingResearchSARS-CoV-2 infectionSARS-CoV-2 variantSamplingScientistServicesSeveritiesSmall Business Innovation Research GrantStatistical ModelsTechniquesTest ResultTestingTimeTranslatingTrustVariantViralVirusVirus DiseasesWorkbasecommercializationcommunity organizationscostdata integrationdata modelinggenomic signaturehealth care availabilityhealth disparityhigh rewardhigh riskimprovedinnovationinterestmachine learning methodmachine learning modelnext generationnovelpathogenpathogenic viruspolicy recommendationpoor communitiespopulation basedpredictive modelingpreventprogramsresearch and developmentstatisticsuptakewastewater monitoringwastewater samplingwastewater testing
项目摘要
Project Summary. The COVID-19 pandemic has magnified the need for enhanced ability to accurately
anticipate future outbreaks due to novel and endemic viral pathogens. Without systematic surveillance, the
ability to head off outbreaks before they occur is challenging: the data from positive human test results is often
too late to prevent a major outbreak from occurring, despite substantial lockdown efforts. The key reason for
this delay is that people are infectious for days before (and if) they are diagnosed positive. We can no longer
rely on population-based testing, which (a) is delayed; (b) is non-random and expensive, exacerbating well-
known and understood health disparities; and (c) relies on highly accurate, widely distributed test availability
and use. Over the last fourteen months, our team of affiliated scientists has developed and implemented a
wastewater-sampling approach to monitor for COVID-19 and other viral pathogens. Our approach utilizes
unique genomic signatures of SARS-CoV-2 (the virus that causes COVID-19) to detect this pathogen in
wastewater, providing inexpensive and unbiased real-time data on COVID-19 infections in communities and
organizations. Our group has begun to contract with municipalities, academic entities and large manufacturing
companies to provide real-time, unbiased data on the presence of COVID-19. Currently, however, wastewater
COVID-19 data has primarily been used solely to determine the presence/absence of SARS-CoV-2 in
samples. We see a highly innovative and impactful opportunity to leverage these data further to anticipate the
timing, location, and severity of future outbreaks from SARS-CoV-2 and other novel and endemic viral
pathogens. The Superior Statistical Research (SSR) R&D team is an internationally recognized group of
wastewater and public health experts with cross-cutting expertise in statistics, data analysis, modelling,
computing, wastewater monitoring, and the ability to translate wastewater and health information into
actionable steps for organizations and communities. To address this opportunity, we propose a Phase I proof-
of-concept SBIR project with two Aims. First, we will demonstrate that it is possible to anticipate locations and
organizations with future outbreaks of COVID-19 with significant lead time. Second, we will demonstrate how
model predictions can be optimized to be useful for municipalities and organizations. Feasibility will be
determined by having models with excellent predictive ability (R2>0.90) (Aim 1) and by demonstrating the
profitability of the commercialization pathway (Aim 2). Phase I feasibility will allow us to extend modelling
capabilities beyond SARS-CoV-2 to other viral pathogens (e.g., influenza, norovirus, HIV): expanding
wastewater testing capabilities for these additional pathogens, and further roll-out and improvement of the
machine-learning/modelling effort in Phase II. Ultimately, we will have a full-service commercial set of
predictive models (Phase III) that can be combined with wastewater-monitoring programs at the community
and organizational level, leading to dramatic reductions in viral disease outbreaks.
项目摘要。 COVID-19大流行已经放大了对准确能力的需求
预期由于新颖和地方性病毒病原体而引起的未来爆发。没有系统的监视,
在发生之前爆发爆发的能力是具有挑战性的:来自正面人类测试结果的数据通常是
尽管大量努力努力,但为时已晚,无法防止重大爆发发生。关键原因
这种延迟是人们在几天前(如果)被诊断为阳性。我们再也不能
依靠基于人群的测试,该测试延迟了; (b)非随机且昂贵,加剧了
已知并了解健康差异; (c)依靠高度准确,分布广泛的测试可用性
并使用。在过去的14个月中,我们的附属科学家团队已经开发并实施了
废水采样方法以监测COVID-19和其他病毒病原体。我们的方法利用
SARS-COV-2的独特基因组特征(导致COVID-19的病毒)检测这种病原体
废水,提供有关社区和社区的共同感染的廉价且公正的实时数据
组织。我们的小组已开始与市政当局,学术实体和大型制造
公司提供有关COVID-19的实时,公正的数据。但是,目前是废水
COVID-19数据主要用于确定SARS-COV-2在中的存在/不存在
样品。我们看到了一个高度创新和有影响力的机会,可以进一步利用这些数据以预测
SARS-COV-2和其他小说和特有病毒的未来爆发的时间,位置和严重性
病原体。高级统计研究(SSR)R&D团队是一个国际认可的小组
具有统计学,数据分析,建模,数据的跨裁切专业知识的废水和公共卫生专家
计算,废水监测以及将废水和健康信息转化为
为组织和社区采取可行的步骤。为了解决这个机会,我们提出了I阶段证明 -
Concept Sbir项目具有两个目标。首先,我们将证明可以预见地点和
与未来的Covid-19的未来爆发的组织具有大量的交付时间。第二,我们将证明如何
模型预测可以优化,可对市政当局和组织有用。可行性将是
通过具有具有出色预测能力(R2> 0.90)(AIM 1)的模型来确定
商业化途径的盈利能力(AIM 2)。第一阶段的可行性将使我们能够扩展建模
SARS-COV-2超出其他病毒病原体的能力(例如流感,诺如病毒,艾滋病毒):扩展
这些其他病原体的废水测试能力,以及进一步的推出和改进
II阶段的机器学习/建模工作。最终,我们将拥有全方位服务的商业集
预测模型(第三阶段)可以与社区的废水监测计划结合
和组织层面,导致病毒疾病暴发的大幅减少。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathan L Tintle其他文献
Nathan L Tintle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathan L Tintle', 18)}}的其他基金
Novel methods to improve the utility of genomics summary statistics
提高基因组学汇总统计效用的新方法
- 批准号:
10646125 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Wastewater data integration and modelling to accurately predict community and organizational outbreaks due to viral pathogens
废水数据集成和建模,以准确预测病毒病原体引起的社区和组织爆发
- 批准号:
10768053 - 财政年份:2022
- 资助金额:
$ 25.96万 - 项目类别:
Large-scale data integration and harmonization to accurately predict sites facing future health-based drinking water crises
大规模数据整合和协调,以准确预测未来面临健康饮用水危机的地点
- 批准号:
10253600 - 财政年份:2021
- 资助金额:
$ 25.96万 - 项目类别:
Analyzing the behavior and interpreting the results of gene based tests of rare variant association
分析罕见变异关联的行为并解释基于基因的测试结果
- 批准号:
9099474 - 财政年份:2012
- 资助金额:
$ 25.96万 - 项目类别:
Analyzing the behavior and interpreting the results of gene based tests of rare v
分析稀有病毒的行为并解释基于基因的测试结果
- 批准号:
8367623 - 财政年份:2012
- 资助金额:
$ 25.96万 - 项目类别:
Analyzing the behavior and interpreting the results of gene based tests of rare variant association
分析罕见变异关联的行为并解释基于基因的测试结果
- 批准号:
9813293 - 财政年份:2012
- 资助金额:
$ 25.96万 - 项目类别:
Evaluating the Cost Effectiveness of Alternative Sample Designs for Genetic Assoc
评估遗传关联替代样本设计的成本效益
- 批准号:
7841342 - 财政年份:2009
- 资助金额:
$ 25.96万 - 项目类别:
Evaluating the Cost Effectiveness of Alternative Sample Designs for Genetic Assoc
评估遗传关联替代样本设计的成本效益
- 批准号:
8264409 - 财政年份:2008
- 资助金额:
$ 25.96万 - 项目类别:
Evaluating the Cost Effectiveness of Alternative Sample Designs for Genetic Assoc
评估遗传关联替代样本设计的成本效益
- 批准号:
7363067 - 财政年份:2008
- 资助金额:
$ 25.96万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Discovery-Driven Mathematics and Artificial Intelligence for Biosciences and Drug Discovery
用于生物科学和药物发现的发现驱动数学和人工智能
- 批准号:
10551576 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Neuroprotective Potential of Vaccination Against SARS-CoV-2 in Nonhuman Primates
SARS-CoV-2 疫苗对非人灵长类动物的神经保护潜力
- 批准号:
10646617 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
- 批准号:
10661931 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 25.96万 - 项目类别: